|
|
 |
|
| Research and Development |
|
|
|
|
|
|
LETI’s
Research and Development and
Clinical
Research laboratories
develop a number of lines of research within the company strategy of offering products
that are increasingly competitive on the allergy diagnosis and treatment markets.
The company’s scientific policy and technological development of these products
are based on studies carried out in LETI’s
R&D laboratories
located in Tres Cantos, Madrid. Most of the products developed as a result of these
studies are protected by both European and American patents.
Research
and Development lines
The
main objectives of our research policy are:
 |
 |
|
To
improve the quality and characterisation of allergenic extracts used in the diagnosis
and treatment of allergic diseases. |
|
| |
|
|
To
define the structural, physico-chemical and biochemical properties of allergens (substances
causing allergic diseases) and to investigate their behaviour after various physical
and chemical treatments. |
|
| |
|
|
To
investigate the composition and standardisation of new allergenic extracts. |
|
| |
|
|
To
investigate the consistency, efficacy and safety of new allergens and/or new forms
of therapeutic vaccines for the treatment of allergic disorders. |
|
|
|
|
|
